These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29113380)

  • 1. Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.
    Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Oct; 8(46):81204-81214. PubMed ID: 29113380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.
    Kim DK; Lee JY; Jung JH; Hah YS; Cho KS
    Investig Clin Urol; 2019 Mar; 60(2):64-74. PubMed ID: 30838338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
    Chen J; Zhang H; Sun G; Zhang X; Zhao J; Liu J; Shen P; Shi M; Zeng H
    Int J Surg; 2018 Apr; 52():214-220. PubMed ID: 29496649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Vashistha V; Wang H; Mazzone A; Liss MA; Svatek RS; Schleicher M; Kaushik D
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1002-1020. PubMed ID: 28332983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis.
    Krajewski W; Nowak Ł; Moschini M; Poletajew S; Chorbińska J; Necchi A; Montorsi F; Briganti A; Sanchez-Salas R; Shariat SF; Palou J; Babjuk M; Teoh JY; Soria F; Pradere B; Ornaghi PI; Pawlak A; Dembowski J; Zdrojowy R
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis.
    Ding H; Fan N; Ning Z; Ma D
    Front Oncol; 2020; 10():564779. PubMed ID: 33154943
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.
    Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Vavassori I; Barni S
    Eur Urol; 2014 Feb; 65(2):350-7. PubMed ID: 23849998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different timing of blood transfusion on oncological outcomes of patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis.
    Ma SY; An Y; Sun JX; Xu MY; Liu CQ; Xu JZ; Zhong XY; Zeng N; He HD; Xia QD; Wang SG
    Front Oncol; 2023; 13():1223592. PubMed ID: 37719020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adjuvant chemotherapy after radical surgery in patients with lymph node-positive bladder cancer or locally advanced (pT3, pT4a) bladder cancer: a meta-analysis and systematic review.
    Chen C; Wang C; Huang H; Li H; Wen Z; Liu Y; Yang XS
    Int J Surg; 2024 Nov; 110(11):7268-7280. PubMed ID: 39017737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing trimodal therapy with radical cystectomy in muscle-invasive bladder cancer: an updated meta-analysis.
    Al-Qudimat AR; Singh K; Ojha LK; Moustafa DA; Elaarag M; Al-Zoubi RM; Aboumarzouk OM
    Front Surg; 2023; 10():1276746. PubMed ID: 38130884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis.
    Qi W; Zhong M; Jiang N; Zhou Y; Lv G; Li R; Shi B; Chen S
    Front Oncol; 2022; 12():986150. PubMed ID: 36505883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.
    Oh JJ; Byun SS; Jeong CW; Kwak C; Kim HH; Ku JH
    Front Oncol; 2019; 9():158. PubMed ID: 30941309
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis.
    Cai Z; Jin H; Chen J; Hu J; Li H; Yi Z; Zu X
    Transl Androl Urol; 2021 Jan; 10(1):283-291. PubMed ID: 33532317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of perioperative blood transfusions on oncological outcomes of patients with bladder cancer undergoing radical cystectomy: A systematic review.
    Volz Y; Eismann L; Pfitzinger PL; Jokisch JF; Buchner A; Schlenker B; Stief CG; Schulz GB
    Arab J Urol; 2020 Dec; 19(1):24-30. PubMed ID: 33763245
    [No Abstract]   [Full Text] [Related]  

  • 17. The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials.
    Jang HJ; Kim BJ; Kim JH; Kim HS
    Oncotarget; 2017 Sep; 8(42):73009-73016. PubMed ID: 29069844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials.
    Liang RF; Zheng LL
    Drug Des Devel Ther; 2015; 9():4471-8. PubMed ID: 26300630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase
    Yoon HS; Kwak C; Kim HH; Kim HS; Ku JH
    Front Oncol; 2019; 9():679. PubMed ID: 31403033
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.